Iannazzo, S., Mannucci, E. and Mantovani, L. (2016) “[Budget impact analysis of empagliflozin for the treatment of type 2 diabetes in Italy]”, Farmeconomia. Health economics and therapeutic pathways, 17(1), pp. 19–27. doi: 10.7175/fe.v17i1.1238.